Bromhexine-UBF

Selected form

Pills

Method of action: 

Treatment option:

Dosage (Posology) and method of administration

Inside, adults and children over 14 years — 8-16 mg 3 times a day, children under 14 years and patients weighing less than 50 kg-8 mg 3 times a day, children under 6 years - 4 mg 3 times a day.

Undesirable effects

In rare cases, dyspeptic disorders, allergic reactions.

Name of the medicinal product

Bromhexine-UBF

Qualitative and quantitative composition

Bromhexine

Pharmaceutical form

Jelly beans

Therapeutic indications

Acute and chronic diseases of the bronchi and lungs with impaired sputum discharge.

Contraindications

Hypersensitivity.

Pharmacokinetic properties

Almost completely absorbed. Binding to plasma proteins-99%. The volume of distribution is about 7 l/kg. Penetrates through the BBB and placental barrier, as well as into breast milk. T1/2 — from 1 to 16 hours. It is excreted only in the urine in the form of metabolites.

Pharmacotherapeutic group

  • Secretolytics and stimulants of motor function of the respiratory tract

Incompatibilities

Promotes the penetration of antibiotics (erythromycin, cephalexin, oxytetracycline) into the lung tissue.

ATC - Anatomical and therapeutic chemical classification

R05CB02 Bromhexine

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Medically reviewed by 

. Last updated on 6/26/2023

Available in countries:

Equivalent of Bromhexine-UBF found in: